CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway
Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2...
Saved in:
| Published in | Cell death & disease Vol. 13; no. 9; pp. 796 - 14 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
19.09.2022
Springer Nature B.V Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2041-4889 2041-4889 |
| DOI | 10.1038/s41419-022-05240-7 |
Cover
| Abstract | Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVs
WEE2-AS1
leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVs
WEE2-AS1
interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis. |
|---|---|
| AbstractList | Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVs
WEE2-AS1
leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVs
WEE2-AS1
interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis. Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis. Abstract Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis. Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis. Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVs leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVs interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis. |
| ArticleNumber | 796 |
| Author | Tan, Yuqian Zhou, Jiahui Yang, Peng Jin, Chi Wang, Tuo Wang, Lu Sun, Yueming Zhang, Dongsheng Peng, Chaofan Feng, Yifei Ji, Jiangzhou |
| Author_xml | – sequence: 1 givenname: Peng surname: Yang fullname: Yang, Peng organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 2 givenname: Dongsheng surname: Zhang fullname: Zhang, Dongsheng organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 3 givenname: Tuo surname: Wang fullname: Wang, Tuo organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 4 givenname: Jiangzhou surname: Ji fullname: Ji, Jiangzhou organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 5 givenname: Chi surname: Jin fullname: Jin, Chi organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 6 givenname: Chaofan surname: Peng fullname: Peng, Chaofan organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 7 givenname: Yuqian surname: Tan fullname: Tan, Yuqian organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 8 givenname: Jiahui surname: Zhou fullname: Zhou, Jiahui organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 9 givenname: Lu surname: Wang fullname: Wang, Lu organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 10 givenname: Yifei surname: Feng fullname: Feng, Yifei email: fengyifei1982@163.com organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University – sequence: 11 givenname: Yueming orcidid: 0000-0002-0543-134X surname: Sun fullname: Sun, Yueming email: sunyueming@njmu.edu.cn organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36123327$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUstu1DAUjVARLaU_wAJZYsMm4FdeG6RhNKWViroAxNK6cW4yHmXsYHumzBfw2ySdobRdVHjjxz3n6Pie-zI5ss5ikrxm9D2jovwQJJOsSinnKc24pGnxLDnhVLJUlmV1dO98nJyFsKLjEoLyLH-RHIuccSF4cZL8ns_O0wa92WJD8JcLbg09-bFY8HT2lZEWtOlNhIiBaNc7jzqOdQ1WoyeDd53HEIyzZGtguq9dNLYjDXYeGohTxbXky_UnNiPREWOXpjaRxCWSCzMMjgwQlzewe5U8b6EPeHbYT5Pv54tv84v06vrz5Xx2lepM0pjKos3ykmmmacm4LjGDApiuWS5AYImyqQWTGbI8R57XFEXethRa3tQcQaM4TS73uo2DlRq8WYPfKQdG3T443ynw0egeFc2yQreiQawyKShCU8icMiplBW1bFqOW2Gtt7AC7G-j7O0FG1ZSS2qekxpTUbUpqYn3cs4ZNvcZGo40e-gdWHlasWarObVUly4yxahR4dxDw7ucGQ1RrEzT2PVh0m6B4wXJaFgVnI_TtI-jKbbwdGzyhspwzWU2O3tx3dGfl75SMgHIP0N6F4LFVepqJMdzRoOmf_i1_RP2vFh0aG0aw7dD_s_0E6w_fEPIJ |
| CitedBy_id | crossref_primary_10_1007_s00432_023_05273_1 crossref_primary_10_3390_nu15214512 crossref_primary_10_3390_biomedicines11061761 crossref_primary_10_1016_j_bbrc_2022_12_026 crossref_primary_10_3389_fimmu_2023_1161628 crossref_primary_10_3390_ncrna10060054 crossref_primary_10_1016_j_bbagen_2025_130796 crossref_primary_10_3389_fimmu_2024_1469918 crossref_primary_10_1016_j_canlet_2024_217244 crossref_primary_10_1016_j_plabm_2025_e00464 crossref_primary_10_1038_s41420_024_02235_5 crossref_primary_10_3390_ijms252312548 crossref_primary_10_1016_j_cca_2024_117849 crossref_primary_10_1186_s12943_023_01860_5 crossref_primary_10_1038_s41420_023_01760_z crossref_primary_10_2147_JIR_S460730 crossref_primary_10_1016_j_intimp_2024_113666 crossref_primary_10_1080_19768354_2023_2281370 crossref_primary_10_3390_biomedicines11092411 crossref_primary_10_20517_evcna_2024_16 crossref_primary_10_3390_cancers15041107 crossref_primary_10_3389_fonc_2024_1374742 crossref_primary_10_7717_peerj_16159 crossref_primary_10_1016_j_trsl_2024_04_003 crossref_primary_10_31083_j_fbl2811302 crossref_primary_10_3389_fonc_2022_1014949 crossref_primary_10_1039_D3NR05656B crossref_primary_10_3390_cells13141195 crossref_primary_10_1016_j_bbamcr_2024_119827 crossref_primary_10_1038_s41467_024_46531_1 crossref_primary_10_3390_cancers15030959 crossref_primary_10_1007_s00239_023_10150_z |
| Cites_doi | 10.1152/physrev.00048.2019 10.1038/s41467-021-22638-7 10.1038/nrgastro.2016.59 10.1053/j.gastro.2019.11.029 10.1038/ncomms2791 10.1186/s12943-019-1043-x 10.1158/0008-5472.CAN-18-3962 10.1080/20013078.2019.1703244 10.1016/j.cell.2009.02.006 10.3892/mmr.2020.11625 10.1038/s41467-018-07810-w 10.1016/S0140-6736(19)32319-0 10.1158/1078-0432.CCR-17-2376 10.1186/s12943-018-0831-z 10.1016/j.bbrc.2020.01.170 10.1001/jamaoncol.2018.7229 10.1186/s12943-019-0957-7 10.1038/onc.2016.353 10.1186/s13059-018-1604-0 10.1038/nrc3458 10.1146/annurev-biochem-060815-014922 10.1101/gad.1602907 10.1038/s41571-020-00457-x 10.1038/s41573-018-0004-1 10.1038/s41575-019-0115-0 10.1016/j.bbrc.2018.11.091 10.1083/jcb.201211138 10.1158/2159-8290.CD-13-0202 10.1038/s41467-017-02583-0 10.1016/j.celrep.2019.11.035 10.1016/j.cub.2020.06.081 10.1186/s12943-019-1019-x 10.1146/annurev-biochem-013118-111829 10.1056/NEJMcibr1914890 10.1016/j.cmet.2019.06.001 10.1186/s12943-018-0863-4 10.1007/BF02705243 10.1002/ctm2.211 10.1126/science.aau6977 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1038/s41419-022-05240-7 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Science Database (ProQuest) Biological Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2041-4889 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_0557cf3dee95430ead746010449aff87 10.1038/s41419-022-05240-7 PMC9485119 36123327 10_1038_s41419_022_05240_7 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO E3Z EBLON EBS EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 5PM ADRAZ ADTOC CAG COF EJD IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c540t-47f5681c1c0812c8e5a7a1cb163a3e8e4db3145e166e26b0e36ff0af2db2eace3 |
| IEDL.DBID | M48 |
| ISSN | 2041-4889 |
| IngestDate | Fri Oct 03 12:52:38 EDT 2025 Sun Oct 26 03:39:59 EDT 2025 Tue Sep 30 17:19:11 EDT 2025 Fri Sep 05 13:16:04 EDT 2025 Tue Oct 07 06:49:26 EDT 2025 Thu Jan 02 22:52:31 EST 2025 Thu Apr 24 23:08:10 EDT 2025 Wed Oct 01 04:27:42 EDT 2025 Fri Feb 21 02:37:09 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-47f5681c1c0812c8e5a7a1cb163a3e8e4db3145e166e26b0e36ff0af2db2eace3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0543-134X |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41419-022-05240-7 |
| PMID | 36123327 |
| PQID | 2715621497 |
| PQPubID | 2041963 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0557cf3dee95430ead746010449aff87 unpaywall_primary_10_1038_s41419_022_05240_7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9485119 proquest_miscellaneous_2716087721 proquest_journals_2715621497 pubmed_primary_36123327 crossref_citationtrail_10_1038_s41419_022_05240_7 crossref_primary_10_1038_s41419_022_05240_7 springer_journals_10_1038_s41419_022_05240_7 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-09-19 |
| PublicationDateYYYYMMDD | 2022-09-19 |
| PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-19 day: 19 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Cell death & disease |
| PublicationTitleAbbrev | Cell Death Dis |
| PublicationTitleAlternate | Cell Death Dis |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
| References | Dekker, Tanis, Vleugels, Kasi, Wallace (CR2) 2019; 394 Anderson, Simon (CR9) 2020; 30 Lignitto, Arcella, Sepe, Rinaldi, Delle Donne, Gallo (CR27) 2013; 4 Song, Wang, Chi, Wei, Xu, Yu (CR28) 2019; 29 Chen, Song (CR6) 2019; 18 Kastrinos, Samadder, Burt (CR4) 2020; 158 Hinshaw, Shevde (CR5) 2019; 79 CR39 Ma, Meng, Chen, Guan (CR32) 2019; 88 Fang, Lv, Lv, Li, Wang, Han (CR17) 2018; 9 CR13 Ignatiadis, Sledge, Jeffrey (CR36) 2021; 18 Ye, Ling, Zheng, Xu (CR37) 2019; 18 Herrera, Llorens, Rodriguez, Herrera, Ramos, Gil (CR20) 2018; 17 Hu, Wang, Lan, Zeng, Liang, Yan (CR16) 2019; 18 Biffi, Tuveson (CR10) 2021; 101 Ponting, Oliver, Reik (CR22) 2009; 136 Hong, Meng, Guan (CR33) 2016; 13 Zhao, Wei, Li, Udan, Yang, Kim (CR34) 2007; 21 DeBerardinis (CR8) 2020; 382 Bregni, Sciallero, Sobrero (CR3) 2019; 5 Harvey, Zhang, Thomas (CR35) 2013; 13 Karreth, Pandolfi (CR21) 2013; 3 Jiang, Wang, Lin, Ma, Cui, Wang (CR31) 2020; 22 Zeng, Li, Pan, Lan, Song, Sun (CR38) 2018; 9 Vitale, Manic, Coussens, Kroemer, Galluzzi (CR7) 2019; 30 Wang, Yang, Chen, Liu, Guo, Zhu (CR23) 2019; 18 Nandi, Tahiliani, Kumar, Chandu (CR25) 2006; 31 Sun, Yang, Zhou, Wang, Song, Li (CR14) 2018; 17 Richards, Zeleniak, Fishel, Wu, Littlepage, Hill (CR19) 2017; 36 Kobayashi, Enomoto, Woods, Burt, Takahashi, Worthley (CR11) 2019; 16 Hu, Huang, Yan, Zhou, Wang, Wu (CR30) 2019; 508 Raposo, Stoorvogel (CR12) 2013; 200 Siegel, Miller, Jemal (CR1) 2019; 69 Zheng, Shabek (CR26) 2017; 86 Qin, Guo, Wang, Zhu, Yan, Wang (CR15) 2019; 20 Wang, Huang, Qian, Wang, Zheng, Jiang (CR29) 2020; 526 Catalano, O’Driscoll (CR18) 2020; 9 Chen, Chen, Yu, Nie, Yan, Ma (CR24) 2018; 24 Low, Wong, Wu, Kong, Png, Cho (CR40) 2021; 12 T Fang (5240_CR17) 2018; 9 JL Hu (5240_CR16) 2019; 18 M Herrera (5240_CR20) 2018; 17 M Catalano (5240_CR18) 2020; 9 E Dekker (5240_CR2) 2019; 394 Z Zeng (5240_CR38) 2018; 9 G Bregni (5240_CR3) 2019; 5 FA Karreth (5240_CR21) 2013; 3 F Kastrinos (5240_CR4) 2020; 158 Q Ye (5240_CR37) 2019; 18 5240_CR39 5240_CR13 L Lignitto (5240_CR27) 2013; 4 I Vitale (5240_CR7) 2019; 30 DC Hinshaw (5240_CR5) 2019; 79 J Song (5240_CR28) 2019; 29 B Jiang (5240_CR31) 2020; 22 RJ DeBerardinis (5240_CR8) 2020; 382 N Zheng (5240_CR26) 2017; 86 X Chen (5240_CR24) 2018; 24 NM Anderson (5240_CR9) 2020; 30 S Ma (5240_CR32) 2019; 88 H Kobayashi (5240_CR11) 2019; 16 Y Wang (5240_CR23) 2019; 18 RL Siegel (5240_CR1) 2019; 69 R Wang (5240_CR29) 2020; 526 X Qin (5240_CR15) 2019; 20 D Nandi (5240_CR25) 2006; 31 KE Richards (5240_CR19) 2017; 36 HB Low (5240_CR40) 2021; 12 X Chen (5240_CR6) 2019; 18 B Zhao (5240_CR34) 2007; 21 Z Sun (5240_CR14) 2018; 17 G Biffi (5240_CR10) 2021; 101 G Raposo (5240_CR12) 2013; 200 AW Hong (5240_CR33) 2016; 13 M Ignatiadis (5240_CR36) 2021; 18 CP Ponting (5240_CR22) 2009; 136 Z Hu (5240_CR30) 2019; 508 KF Harvey (5240_CR35) 2013; 13 |
| References_xml | – volume: 101 start-page: 147 year: 2021 end-page: 76 ident: CR10 article-title: Diversity and biology of cancer-associated fibroblasts publication-title: Physiol Rev doi: 10.1152/physrev.00048.2019 – volume: 12 year: 2021 ident: CR40 article-title: DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death publication-title: Nat Commun doi: 10.1038/s41467-021-22638-7 – ident: CR39 – volume: 13 start-page: 324 year: 2016 end-page: 37 ident: CR33 article-title: The Hippo pathway in intestinal regeneration and disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2016.59 – volume: 158 start-page: 389 year: 2020 end-page: 403 ident: CR4 article-title: Use of family history and genetic testing to determine risk of colorectal cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.11.029 – volume: 4 year: 2013 ident: CR27 article-title: Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth publication-title: Nat Commun doi: 10.1038/ncomms2791 – volume: 18 year: 2019 ident: CR37 article-title: Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA publication-title: Mol cancer doi: 10.1186/s12943-019-1043-x – volume: 79 start-page: 4557 year: 2019 end-page: 66 ident: CR5 article-title: The tumor microenvironment innately modulates cancer progression publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-18-3962 – volume: 9 start-page: 1703244 year: 2020 ident: CR18 article-title: Inhibiting extracellular vesicles formation and release: a review of EV inhibitors publication-title: J Extracell Vesicles doi: 10.1080/20013078.2019.1703244 – volume: 136 start-page: 629 year: 2009 end-page: 41 ident: CR22 article-title: Evolution and functions of long noncoding RNAs publication-title: Cell doi: 10.1016/j.cell.2009.02.006 – volume: 22 start-page: 5069 year: 2020 end-page: 82 ident: CR31 article-title: Antisense long non‑coding RNA WEE2‑AS1 regulates human vascular endothelial cell viability via cell cycle G2/M transition in arteriosclerosis obliterans publication-title: Mol Med Rep doi: 10.3892/mmr.2020.11625 – volume: 9 year: 2018 ident: CR38 article-title: Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis publication-title: Nat Commun doi: 10.1038/s41467-018-07810-w – volume: 394 start-page: 1467 year: 2019 end-page: 80 ident: CR2 article-title: Colorectal cancer publication-title: Lancet doi: 10.1016/S0140-6736(19)32319-0 – volume: 24 start-page: 2002 year: 2018 end-page: 14 ident: CR24 article-title: Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-2376 – volume: 17 year: 2018 ident: CR14 article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment publication-title: Mol Cancer doi: 10.1186/s12943-018-0831-z – volume: 526 start-page: 1005 year: 2020 end-page: 12 ident: CR29 article-title: LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2020.01.170 – volume: 5 start-page: 605 year: 2019 end-page: 6 ident: CR3 article-title: HER2 amplification and anti-EGFR sensitivity in advanced colorectal cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.7229 – volume: 18 year: 2019 ident: CR23 article-title: A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis publication-title: Mol Cancer doi: 10.1186/s12943-019-0957-7 – volume: 36 start-page: 1770 year: 2017 end-page: 8 ident: CR19 article-title: Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells publication-title: Oncogene doi: 10.1038/onc.2016.353 – volume: 20 year: 2019 ident: CR15 article-title: Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5 publication-title: Genome Biol doi: 10.1186/s13059-018-1604-0 – volume: 13 start-page: 246 year: 2013 end-page: 57 ident: CR35 article-title: The Hippo pathway and human cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc3458 – volume: 86 start-page: 129 year: 2017 end-page: 57 ident: CR26 article-title: Ubiquitin ligases: structure, function, and regulation publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-060815-014922 – volume: 69 start-page: 7 year: 2019 end-page: 34 ident: CR1 article-title: Cancer statistics, 2019 publication-title: CA: Cancer J. Clin – volume: 21 start-page: 2747 year: 2007 end-page: 61 ident: CR34 article-title: Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control publication-title: Genes Dev doi: 10.1101/gad.1602907 – ident: CR13 – volume: 18 start-page: 297 year: 2021 end-page: 312 ident: CR36 article-title: Liquid biopsy enters the clinic—implementation issues and future challenges publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-00457-x – volume: 18 start-page: 99 year: 2019 end-page: 115 ident: CR6 article-title: Turning foes to friends: targeting cancer-associated fibroblasts publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-018-0004-1 – volume: 16 start-page: 282 year: 2019 end-page: 95 ident: CR11 article-title: Cancer-associated fibroblasts in gastrointestinal cancer publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0115-0 – volume: 508 start-page: 79 year: 2019 end-page: 86 ident: CR30 article-title: Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.11.091 – volume: 200 start-page: 373 year: 2013 end-page: 83 ident: CR12 article-title: Extracellular vesicles: exosomes, microvesicles, and friends publication-title: J Cell Biol doi: 10.1083/jcb.201211138 – volume: 3 start-page: 1113 year: 2013 end-page: 21 ident: CR21 article-title: ceRNA cross-talk in cancer: when ce-bling rivalries go awry publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-13-0202 – volume: 9 year: 2018 ident: CR17 article-title: Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer publication-title: Nat Commun doi: 10.1038/s41467-017-02583-0 – volume: 29 start-page: 3664 year: 2019 end-page: 3677 ident: CR28 article-title: Kindlin-2 inhibits the hippo signaling pathway by promoting degradation of MOB1 publication-title: Cell Rep doi: 10.1016/j.celrep.2019.11.035 – volume: 30 start-page: R921 year: 2020 end-page: r925 ident: CR9 article-title: The tumor microenvironment publication-title: Curr Biol: CB doi: 10.1016/j.cub.2020.06.081 – volume: 18 year: 2019 ident: CR16 article-title: CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer publication-title: Mol Cancer doi: 10.1186/s12943-019-1019-x – volume: 88 start-page: 577 year: 2019 end-page: 604 ident: CR32 article-title: The Hippo pathway: biology and pathophysiology publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-013118-111829 – volume: 382 start-page: 869 year: 2020 end-page: 71 ident: CR8 article-title: Tumor microenvironment, metabolism, and immunotherapy publication-title: N Engl J Med doi: 10.1056/NEJMcibr1914890 – volume: 30 start-page: 36 year: 2019 end-page: 50 ident: CR7 article-title: Macrophages and metabolism in the tumor microenvironment publication-title: Cell Metab doi: 10.1016/j.cmet.2019.06.001 – volume: 17 year: 2018 ident: CR20 article-title: Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer publication-title: Mol Cancer doi: 10.1186/s12943-018-0863-4 – volume: 31 start-page: 137 year: 2006 end-page: 55 ident: CR25 article-title: The ubiquitin-proteasome system publication-title: J Biosci doi: 10.1007/BF02705243 – volume: 508 start-page: 79 year: 2019 ident: 5240_CR30 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.11.091 – volume: 31 start-page: 137 year: 2006 ident: 5240_CR25 publication-title: J Biosci doi: 10.1007/BF02705243 – ident: 5240_CR39 doi: 10.1002/ctm2.211 – volume: 86 start-page: 129 year: 2017 ident: 5240_CR26 publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-060815-014922 – volume: 30 start-page: 36 year: 2019 ident: 5240_CR7 publication-title: Cell Metab doi: 10.1016/j.cmet.2019.06.001 – volume: 9 start-page: 1703244 year: 2020 ident: 5240_CR18 publication-title: J Extracell Vesicles doi: 10.1080/20013078.2019.1703244 – volume: 9 year: 2018 ident: 5240_CR17 publication-title: Nat Commun doi: 10.1038/s41467-017-02583-0 – volume: 22 start-page: 5069 year: 2020 ident: 5240_CR31 publication-title: Mol Med Rep doi: 10.3892/mmr.2020.11625 – volume: 21 start-page: 2747 year: 2007 ident: 5240_CR34 publication-title: Genes Dev doi: 10.1101/gad.1602907 – ident: 5240_CR13 doi: 10.1126/science.aau6977 – volume: 9 year: 2018 ident: 5240_CR38 publication-title: Nat Commun doi: 10.1038/s41467-018-07810-w – volume: 30 start-page: R921 year: 2020 ident: 5240_CR9 publication-title: Curr Biol: CB doi: 10.1016/j.cub.2020.06.081 – volume: 18 year: 2019 ident: 5240_CR37 publication-title: Mol cancer doi: 10.1186/s12943-019-1043-x – volume: 13 start-page: 324 year: 2016 ident: 5240_CR33 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2016.59 – volume: 394 start-page: 1467 year: 2019 ident: 5240_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(19)32319-0 – volume: 18 start-page: 297 year: 2021 ident: 5240_CR36 publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-00457-x – volume: 5 start-page: 605 year: 2019 ident: 5240_CR3 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.7229 – volume: 382 start-page: 869 year: 2020 ident: 5240_CR8 publication-title: N Engl J Med doi: 10.1056/NEJMcibr1914890 – volume: 18 year: 2019 ident: 5240_CR16 publication-title: Mol Cancer doi: 10.1186/s12943-019-1019-x – volume: 18 start-page: 99 year: 2019 ident: 5240_CR6 publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-018-0004-1 – volume: 101 start-page: 147 year: 2021 ident: 5240_CR10 publication-title: Physiol Rev doi: 10.1152/physrev.00048.2019 – volume: 3 start-page: 1113 year: 2013 ident: 5240_CR21 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-13-0202 – volume: 200 start-page: 373 year: 2013 ident: 5240_CR12 publication-title: J Cell Biol doi: 10.1083/jcb.201211138 – volume: 29 start-page: 3664 year: 2019 ident: 5240_CR28 publication-title: Cell Rep doi: 10.1016/j.celrep.2019.11.035 – volume: 4 year: 2013 ident: 5240_CR27 publication-title: Nat Commun doi: 10.1038/ncomms2791 – volume: 69 start-page: 7 year: 2019 ident: 5240_CR1 publication-title: CA: Cancer J. Clin – volume: 526 start-page: 1005 year: 2020 ident: 5240_CR29 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2020.01.170 – volume: 158 start-page: 389 year: 2020 ident: 5240_CR4 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.11.029 – volume: 17 year: 2018 ident: 5240_CR14 publication-title: Mol Cancer doi: 10.1186/s12943-018-0831-z – volume: 136 start-page: 629 year: 2009 ident: 5240_CR22 publication-title: Cell doi: 10.1016/j.cell.2009.02.006 – volume: 18 year: 2019 ident: 5240_CR23 publication-title: Mol Cancer doi: 10.1186/s12943-019-0957-7 – volume: 36 start-page: 1770 year: 2017 ident: 5240_CR19 publication-title: Oncogene doi: 10.1038/onc.2016.353 – volume: 79 start-page: 4557 year: 2019 ident: 5240_CR5 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-18-3962 – volume: 17 year: 2018 ident: 5240_CR20 publication-title: Mol Cancer doi: 10.1186/s12943-018-0863-4 – volume: 20 year: 2019 ident: 5240_CR15 publication-title: Genome Biol doi: 10.1186/s13059-018-1604-0 – volume: 13 start-page: 246 year: 2013 ident: 5240_CR35 publication-title: Nat Rev Cancer doi: 10.1038/nrc3458 – volume: 24 start-page: 2002 year: 2018 ident: 5240_CR24 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-17-2376 – volume: 88 start-page: 577 year: 2019 ident: 5240_CR32 publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-013118-111829 – volume: 12 year: 2021 ident: 5240_CR40 publication-title: Nat Commun doi: 10.1038/s41467-021-22638-7 – volume: 16 start-page: 282 year: 2019 ident: 5240_CR11 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0115-0 |
| SSID | ssj0000330256 |
| Score | 2.5000815 |
| Snippet | Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression.... Abstract Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor... |
| SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 796 |
| SubjectTerms | 13/1 14/19 14/32 631/67/1504/1885 631/67/327 82 82/51 82/58 Adaptor Proteins, Signal Transducing - metabolism Animals Antibodies Biochemistry Biomedical and Life Sciences Carcinogenesis Cell Biology Cell Culture Cell Cycle Proteins - genetics Cell proliferation Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - pathology Degradation DNA, Antisense Extracellular vesicles Fibroblasts Hippo Signaling Pathway Humans Immunology Life Sciences Medical prognosis Mice Mice, Nude Molecular modelling Proteasome Endopeptidase Complex - metabolism Proteasomes Protein-Tyrosine Kinases - genetics RNA, Long Noncoding - genetics Therapeutic targets Tumor Microenvironment Tumorigenesis Ubiquitin Ubiquitin-protein ligase Ubiquitin-Protein Ligases - genetics Ubiquitin-Protein Ligases - metabolism Ubiquitins Yes-associated protein |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJQQcEG8CBRmJG40aO87ruK12tUIqHKCit8hxxjTSkqy6u233F_RvM2Nnw65AhQPHxLbkeL7xzMTjbxh7r5TMBFDVgAq1SUFehNoWSVhHaZUkWqMJpv-QJ5_S6an6eJacbZX6opwwTw_sF-6QOKKMjWuAIlFxhB-eKRdEqEJbm7t75FFebAVTbg_GMB2NeX9LJorzw4USiu7rYOwVJZLS6HYskSPs_5OX-Xuy5HBi-oDdW7Vzvb7Ss9mWUZo8Yg97b5KP_Fc8ZnegfcLu-vqS66fs5ng0CWvE2CXUHK67RfcDe38bj2U4-iK41cZzdMOCE3k1bX7YbggIF9xlbnnWDn7ZaHqmxL32O6-JYMLXYuKd5Sefj8SILzvetOdN1Sw5-pR82sznHad6x1d6_YydTsZfj6dhX3khNOjBLUOVWSImM8KgxyBNDonOtDAVOm86hhxUXcVCJSDSFGRaRRCn1kbayrqSuJND_JzttV0LLxmvFNRCgMkKFJy0Kq9sEiFsMrScAqwJmNhIoTQ9LTlVx5iV7ng8zksvuRIlVzrJlVnAPgxj5p6U49beRyTcoScRarsXCLOyh1n5N5gFbH8DjbLX8kWJMEf3EWNMbH43NKN-0qGLbqFbuT4pkS5KEbAXHknDTGLivokljs52MLYz1d2Wtjl3HOBE6iNEEbCDDRp_Teu2pTgYEPsPK_fqf6zca3ZfOq0rQlHss73lxQreoCO3rN46nf0JgdhByQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZGJwQ8IG6DwkBG4o1Fix3n9oBQO7WqkFYQMLG3yPFli1SS0stGfwF_m3Ocy6hAFY-J7cjx-Y7PsX38HULeCMFjZjBrQA7aJEySetKmoaf9KA9DKcEE4z7k6TSanIkP5-H5Hpm2d2EwrLKdE91ErSuFe-TH8Ekw1eDPx-_nPzzMGoWnq20KDdmkVtDvHMXYLbLPkRmrR_aHo-mnz92uiw_LdzDyze0ZP0iOl4IJvMcDazI_5Bhet2WhHJH_v7zPv4Mou5PUe-TOupzLzbWczf4wVuMH5H7jZdJBDYuHZM-Uj8jtOu_k5jH5dTIYexqwd2U0NT-rZfUdan8bjbg3-MKolarm7jZLiqTWOClCuUKALKiL6KrZPOhVIfEZA_rKC6qReKLO0UQrS08_DtmAripalJdFXqwo-Jp0UsznFcU8yNdy84ScjUdfTyZek5HBU-DZrTwRWyQsU0yBJ8FVYkIZS6ZycOpkYBIjdB4wERoWRYZHuW-CyFpfWq5zDjO8CQ5Ir6xK84zQXBjNmFFxqmF1bkWS29AHOMVgUZmxqk9YK4VMNXTlmDVjlrlj8yDJasllILnMSS6L--Rt12Zek3XsrD1E4XY1kWjbvagWF1mjtxlSlCkbaGPSUAQ-6F0s3BpWpNLaBD5y2EIja7R_md1gtU9ed8Wgt3gYI0tTrV2dCMkYOeuTpzWSup4EyIkTcGgdb2Fsq6vbJWVx6bjBkeyHsbRPjlo03nRr11AcdYj9j5F7vvunX5C73OlT6rH0kPRWi7V5Ca7bKn_V6ONvuzxACA priority: 102 providerName: ProQuest – databaseName: HAS SpringerNature Open Access 2022 dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbKVohyQLy7UJCRuLERseO8jmm1q9VKhUOp6C2ynTGNtCSrbrZlfwF_m7GTDURFFRwTP2R5vvHM-PENIe-F4DEDmzVAoTYJSFJPmjT0Cj9SYSglmmC7D3n6KZqfi8VFeLFHJru3MIPze0fdvRZM2Ic2GDT5Ibf33-6R_QSBmYzIfpYtzhb9noqPwTma8O5tDDb_eLvxwP44mv6_-Za3r0j256QPyYNNtZLbG7lc_mGKZo_Jo86HpFkr9CdkD6qn5H6bVXL7jPw8yWZegci6hoLCj3pdf8faX6dT7mVnjBqpW2ZuWFNLWW2XPCzXVvxX1N3Xark66HUp7be9rld9o4WllWgzMNHa0NPPxyyjTU3L6rJUZUPRk6TzcrWqqc1yfCO3z8n5bPrlZO51-RY8jX5b44nYWDoyzTT6CVwnEMpYMq3QZZMBJCAKFTARAosi4JHyIYiM8aXhheK4fkPwgoyquoJDQpWAgjHQcVpg7G1EokzoI1hitJcMjB4TtpNCrjsycpsTY5m7Q_EgyVvJ5Si53Ekuj8fkQ99m1VJx3Fn72Aq3r2lptN0PRFfeaWVuCci0CQqANBSBj1oVCxehilQak2AnRzto5J1ur3MENzqNGFli8bu-GLXSHrXICuqNqxNZqkXOxuRli6R-JIFlvAk4to4HGBsMdVhSlZeO-dtS-TCWjslkh8bfw7prKiY9Yv9h5l79X--vyQF3-pV6LD0io-ZqA2_QUWvU204_fwH39DQb priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdGJ8R44PujMJCReGMpceJ8PXZTqwppAwmqjafIds5bRJdUbbpR_gH-bc7OBxSmiT22PlfO5c73u_r8O0Lecu5FDEzXAInexCFOHKGTwMncUAaBEBiCzf-Qh0fhZMo_nAQnWyRs78LYon1LaWm36bY67P2SM26u22Dq5AaeqYIbzDN9i2yHAWLwHtmeHn0afjWd5FyOSVEcJ80NGdePr5i8EYUsWf9VCPPfQsnutPQuubMq5mJ9KWazPwLS-D45bh-lrkP5NlhVcqB-_MXyePNnfUDuNRiVDmvJh2QLikfkdt21cv2Y_DwYjp0MLfcCMgrfy2V5jtLHo5HnDD8zqoWqmb9hSQ0lttlScVwZ81pQWw9Wc4HQi1yYz6YcsDilmaGtqDs80VLTw4_7bEirkubFWS7ziiJSpZN8Pi-p6aJ8KdZPyHQ8-nIwcZp-Do5CXFg5PNKG7kwxhTjEUzEEIhJMSYSEwocYeCZ9xgNgYQheKF3wQ61dob1MehgfwH9KekVZwHNCJYeMMVBRkmFur3ksdeCiMUYYjxlo1Sesfb-pasjOTc-NWWoP3f04rZWcopJTq-Q06pN33Zx5TfVxrfS-MZtO0tB02y_KxWnavMrUEJwp7WcAScB9F7024jYD5onQOsYf2W2NLm32jmWKzoOgFDNXHH7TDaPXm6McUUC5sjKhoXL0WJ88q220W4lvGHV8D2dHG9a7sdTNkSI_s8zihiqIsaRP9lo7_72s61Sx1_nCf2juxc3EX5Idz7pC4rBkl_SqxQpeIRCs5OvG638Bo5RWtg priority: 102 providerName: Unpaywall |
| Title | CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway |
| URI | https://link.springer.com/article/10.1038/s41419-022-05240-7 https://www.ncbi.nlm.nih.gov/pubmed/36123327 https://www.proquest.com/docview/2715621497 https://www.proquest.com/docview/2716087721 https://pubmed.ncbi.nlm.nih.gov/PMC9485119 https://www.nature.com/articles/s41419-022-05240-7.pdf https://doaj.org/article/0557cf3dee95430ead746010449aff87 |
| UnpaywallVersion | publishedVersion |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: KQ8 dateStart: 20100101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQT databaseName: Springer Nature - nature.com Journals - Fully Open Access customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: NAO dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.nature.com/siteindex/index.html providerName: Nature Publishing – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-4889 dateEnd: 20221231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: 7X7 dateStart: 20220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2041-4889 dateEnd: 20221231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: BENPR dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2041-4889 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M48 dateStart: 20100101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: AAJSJ dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: C6C dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZ2EQIeEHcKozISbywsdpzbA0Jp1aqq1DIxKspT5CT2FqkkpZdt_QX8bc5x0kDFNMFTlNiJLJ_v2OfE9vcR8lYI7jOFqgEJeJNQQWhJHbpWZnuJ60oJUzD-hxyNvcFEDKfudI9s5Y7qDlzemNqhntRkMXt__WPzERz-Q3VkPDhZCibwKA6kVbbLcYfcPjmEa4hSDqM63DcjMyTv3Ai6cltA6hQEYX2O5ubP7MxVhtL_pjj07-2UzZrqfXJ3Xczl5krOZn9MW_2H5EEdb9KoAsgjsqeKx-ROpUC5eUJ-dqO-lQEKL1VG1XW5LL9D7a-9HreiM0a1TCsWb7WkSG-NwyOUpwiVBTV7uypeD3qZS7zHrX3FOc2QgqJSa6KlpqNPHRbRVUnz4iJP8hWFqJMO8vm8pKiIfCU3T8mk3_vSHVi1NoOVQoy3soSvkbosZSnEFDwNlCt9ydIEwjvpqECJLHGYcBXzPMW9xFaOp7UtNc8SDmO9cp6Rg6Is1AtCE6EyxlTqhxnk6VoEiXZtAJYPcytTOm0RtrVCnNbE5aifMYvNAroTxJXlYrBcbCwX-y3yrnlnXtF23Fq7g8ZtaiLltnlQLs7j2oNjJCtLtZMpFbrCscEDfWGyWRFKrQP4yNEWGvEWxjE4AgSYkIVC8ZumGDwYl2Vkocq1qeMhLSNnLfK8QlLTEgfZcRwOb_s7GNtp6m5JkV8YlnCk_WEsbJHjLRp_N-u2rjhuEPsPPffyv_r5FbnHjXuFFguPyMFqsVavIaZbJW2y70_9NjmMouHZEK6d3vj0Mzztet22-U_SNq4MJZPxafTtF2coSdA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJzR4QNwpDDASPLFo8SW3hwm1o1XH1oJg0_YWnMTeKpWk9LLSX8C_4rdxTm6jAlW87LG1Yzk5V9vH30fIaym5xzSyBkRgTVL7gaVM4FiJ7UaOoxSEYNyH7A_c3on8cOacbZBf1V0YLKusfGLuqJMsxj3yXRgSQjXk89678XcLWaPwdLWi0FAltUKyl0OMlRc7DvVyAUu46d7Be5D3G867neP9nlWyDFgxZCszS3oGQbhiFkN05LGvHeUpFkeQqCihfS2TSDDpaOa6mruRrYVrjK0MTyIOXksLGPcG2ZQCptYgm-3O4NPnepfHFgKTivK2ji383alkEu8NwRrQdjiW861ExJw44F_Z7t9Fm_XJ7W2yNU_HarlQo9EfwbF7l9wps1raKtTwHtnQ6X1ys-C5XD4gP_dbXSsBXb_UCdU_smn2DXqfdjrcan1h1Ki4wArXU4og2uiEoT1GhZzQvIKsQA-hl0OFv7GAMD2nCQJdFJxQNDO0_7HNWnSW0WF6MYyGMwq5Le0Nx-OMIu_yQi0fkpNrkc0j0kizVD8hNJI6YUzHXpB4khvpR8axQX09iOBMm7hJWCWFMC7h0ZGlYxTmx_TCDwvJhSC5MJdc6DXJ2_qZcQEOsrZ3G4Vb90Rg7_yPbHIeln4iREi02IhE68CRwgY792S-ZpaBMsaHQbYr1QhLbzMNr2yjSV7VzeAn8PBHpTqb531cBH_krEkeF5pUz0QgBo_g8LS3omMrU11tSYcXORY5ggsxFjTJTqWNV9Na9yl2ao39jy_3dP1LvyRbveP-UXh0MDh8Rm7x3LYCiwXbpDGbzPVzSBtn0YvSNin5et3u4DcuGX4O |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGELcHxJ3CACPBE4saXxInDwh1W6uOsYEE0_oWnMTeKpWk9LLSX8B_4tdxTm6jAlW87LG1Yzk537nYPv4OIa-k5IoZrBoQgzZJE4SOtqHnpK4fe57W4IJxH_LwyO8fy_cDb7BBftV3YTCtsraJhaFO8wT3yNswJLhqiOdV21ZpEZ_2eu_G3x2sIIUnrXU5jRIiB2a5gOXb9O3-Hsj6Nee97pfdvlNVGHASiFRmjlQWCbgSloBn5ElgPK00S2IIUrQwgZFpLJj0DPN9w_3YNcK31tWWpzEHi2UEjHuFXFVChJhOqAaq2d9xhcBworqn44qgPZVM4o0hWP25HsdEvhVfWJQM-Fec-3e6ZnNme4vcmGdjvVzo0egPt9i7Q25X8SztlAC8SzZMdo9cKytcLu-Tn7udnpMCys9NSs2PfJp_g94n3S53Op8ZtTopWcLNlCJ9NppfaE8QihNa5I6VvCH0fKjxN6YOZqc0RYqLshoUzS09_LjDOnSW02F2NoyHMwpRLe0Px-OcYsXlhV4-IMeXIpmHZDPLM_OY0FialDGTqDBVklsZxNZzAbgKfDczNmkRVkshSipidKzPMYqKA3oRRKXkIpBcVEguUi3ypnlmXNKCrO29g8JteiKld_FHPjmNKgsRIRlaYkVqTOhJ4YKGK1mslmWorQ1gkK0aGlFlZ6bRhVa0yMumGSwEHvvozOTzoo-PtI-ctcijEknNTASy7wgOT6sVjK1MdbUlG54VLORIK8RY2CLbNRovprXuU2w3iP2PL_dk_Uu_INfBCEQf9o8OnpKbvFCt0GHhFtmcTebmGcSLs_h5oZiUfL1sS_AbtUF7qA |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdGJ8R44PujMJCReGMpceJ8PXZTqwppAwmqjafIds5bRJdUbbpR_gH-bc7OBxSmiT22PlfO5c73u_r8O0Lecu5FDEzXAInexCFOHKGTwMncUAaBEBiCzf-Qh0fhZMo_nAQnWyRs78LYon1LaWm36bY67P2SM26u22Dq5AaeqYIbzDN9i2yHAWLwHtmeHn0afjWd5FyOSVEcJ80NGdePr5i8EYUsWf9VCPPfQsnutPQuubMq5mJ9KWazPwLS-D45bh-lrkP5NlhVcqB-_MXyePNnfUDuNRiVDmvJh2QLikfkdt21cv2Y_DwYjp0MLfcCMgrfy2V5jtLHo5HnDD8zqoWqmb9hSQ0lttlScVwZ81pQWw9Wc4HQi1yYz6YcsDilmaGtqDs80VLTw4_7bEirkubFWS7ziiJSpZN8Pi-p6aJ8KdZPyHQ8-nIwcZp-Do5CXFg5PNKG7kwxhTjEUzEEIhJMSYSEwocYeCZ9xgNgYQheKF3wQ61dob1MehgfwH9KekVZwHNCJYeMMVBRkmFur3ksdeCiMUYYjxlo1Sesfb-pasjOTc-NWWoP3f04rZWcopJTq-Q06pN33Zx5TfVxrfS-MZtO0tB02y_KxWnavMrUEJwp7WcAScB9F7024jYD5onQOsYf2W2NLm32jmWKzoOgFDNXHH7TDaPXm6McUUC5sjKhoXL0WJ88q220W4lvGHV8D2dHG9a7sdTNkSI_s8zihiqIsaRP9lo7_72s61Sx1_nCf2juxc3EX5Idz7pC4rBkl_SqxQpeIRCs5OvG638Bo5RWtg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CAF-derived+exosomal+WEE2-AS1+facilitates+colorectal+cancer+progression+via+promoting+degradation+of+MOB1A+to+inhibit+the+Hippo+pathway&rft.jtitle=Cell+death+%26+disease&rft.au=Yang%2C+Peng&rft.au=Zhang%2C+Dongsheng&rft.au=Wang%2C+Tuo&rft.au=Ji%2C+Jiangzhou&rft.date=2022-09-19&rft.issn=2041-4889&rft.eissn=2041-4889&rft.volume=13&rft.issue=9&rft_id=info:doi/10.1038%2Fs41419-022-05240-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41419_022_05240_7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |